Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR -Mutated Non–Small Cell Lung Cancer

Pasi A. Jänne; Christina Baik; Wu-Chou Su; Melissa L. Johnson; Hidetoshi Hayashi; Makoto Nishio; Dong-Wan Kim; Marianna Koczywas; Kathryn A. Gold; Conor E. Steuer

doi:10.1158/2159-8290.cd-21-0715

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR -Mutated Non–Small Cell Lung Cancer

Identifier:nobleid.org/w1/20260526/CCD5B0EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CCD5B0EB.svg?ark=w1%2F20260526%2FCCD5B0EB)](https://nobleid.org/work/w1/20260526/CCD5B0EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR -Mutated Non–Small Cell Lung Cancer

Identifier:nobleid.org/w1/20260526/CCD5B0EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CCD5B0EB.svg?ark=w1%2F20260526%2FCCD5B0EB)](https://nobleid.org/work/w1/20260526/CCD5B0EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work